Recruiting

Observational Study

Sponsor:

University of Alabama at Birmingham

Code:

NCT05067231

Conditions

Natriuretic Peptides

Cardiovascular Diseases

Hypertension

Diabetes

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal information on a large number of people over time. It will be set up so that it can be used in the future as a resource for researchers undertaking a wide range of medical research.

Conditions

Natriuretic Peptides

Cardiovascular Diseases

Hypertension

Diabetes

Obesity

Study ID

NCT05067231

Start date

Jan 1, 2022

Status verified date

Feb, 2026

Completion date

Jan 1, 2030

Anticipated

Primary completion date

Jan 1, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age more than or equal to 18

Exclusion Criteria:

  • Age <18, at screening
  • Employees or students associated with the Division of Cardiovascular Disease at UAB will not be recruited due to their vulnerable status and susceptibility to coercion.
  • Women who are pregnant or who can become pregnant and not practicing an acceptable method of birth control.

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Genetic Variants in the NPPA and NPPB gene of the Natriuretic Peptide family associated with the Cardiovascular and Metabolic Diseases [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

University of Alabama at Birmingham

Recruiting

Birmingham, Alabama, United States, 35294

Contacts

Principal Investigator:

Pankaj Arora, MD

More Information

Sponsor

University of Alabama at Birmingham

Last update posted

Feb 13, 2026

Last verified

Feb, 2026

Keywords

  • Natriuretic Peptides
  • Cardiovascular Diseases
  • Hypertension
  • Diabetes
  • Obesity

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2026-02-13.